News
There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...
Hosted on MSN21d
New Frontiers at ACC Meeting: Semaglutide, INOCA, & MoreMeanwhile, oral semaglutide (Rybelsus ... will be notable for getting at pulse oximeter bias depending on skin color. Additionally, the sparse data on cardiac arrest in long-distance runners ...
Semaglutide was initially approved under the brand name Ozempic for Type 2 diabetes, while the brand name Wegovy is only approved for weight loss. Here, we’ll compare tirzepatide (Zepbound ...
CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE ...
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...
Stephanie Anderson Witmer is a freelance journalist based in Pennsylvania. Her work has been published in other top magazines and digital publications, including Prevention, Good Housekeeping ...
The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, blocking sales of copycat forms of the drug that have made a lot of money for ...
Single dose of Vivani’s NPM-139 semaglutide implant led to nearly 20% weight loss in rats, suggesting once- or twice-yearly dosing. NPM-139 showed steady semaglutide release with potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results